170 results
8-K
EX-10.2
ALIM
Alimera Sciences Inc.
4 Jan 24
Departure of Directors or Certain Officers
4:01pm
to expense reimbursements in accordance with the Company’s standard policy on expense reimbursements, as in effect from time to time. Any reimbursement … for reimbursement in any calendar year, and (d) not be subject to liquidation or exchange for another benefit.
(h) Indemnification . The Company shall
8-K
EX-10.1
ALIM
Alimera Sciences Inc.
12 Dec 23
Departure of Directors or Certain Officers
5:09pm
standard policy on expense reimbursements, as in effect from time to time. Any reimbursement shall (1) be paid promptly but not later than the last day … for reimbursement in any calendar year and (3) not be subject to liquidation or exchange for another benefit.
(h) Indemnification. The Company shall, to the maximum
8-K
EX-10.2
ALIM
Alimera Sciences Inc.
12 Dec 23
Departure of Directors or Certain Officers
5:09pm
, as in effect from time to time. Any reimbursement shall (a) be for expenses reasonably and necessarily incurred in the performance of Executive’s duties, (b … other expenses that are eligible for reimbursement in any calendar year, and (d) not be subject to liquidation or exchange for another benefit.
(h
8-K
EX-10.1
48c0bx71dvlq qvv
3 Oct 23
Alimera Sciences Appoints Jason Werner as Chief Operating Officer
7:00am
424B3
yzpjec5uiglooh2xzy
12 Jul 23
Prospectus supplement
12:00am
8-K
EX-2.1
uubddd
18 May 23
Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023
4:55pm
8-K
EX-99.1
8cz194i
31 Mar 23
Alimera Sciences Announces 2022 Financial Results and Business Update
8:43am
8-K
EX-99.1
xc8jeqi6x6aakbm79
14 Nov 22
Alimera Sciences Announces Third Quarter 2022 Financial Results
8:34am
8-K
EX-99.1
xe2kx9jpg oh3
27 Jul 22
Alimera Sciences Announces Second Quarter 2022 Financial Results
8:22am